دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Comparative efficacy and safety of tenecteplase and alteplase in acute ischemic stroke: A pairwise and network meta-analysis of randomized controlled trials
Aqeeb Ur Rehman a, Aleenah Mohsin a, Huzaifa Ahmad Cheema a,*, Afra Zahid a, Muhammad Ebaad Ur Rehman b, Muhammad Zain Ameer a, Muhammad Ayyan a, Muhammad Ehsan a, Abia Shahid a,*, Muhammad Aemaz Ur Rehman c, Jaffer Shah d, Ayaz Khawaja
doi : 10.1016/j.jns.2022.120537
Volume 445, 15 February 2023, 120537
Studies on tenecteplase have been yielding mixed results for several important outcomes at different doses, thus hampering objective guideline recommendations in acute ischemic stroke management. This meta-analysis stratifies doses in order to refine our interpretation of outcomes and quantify the benefits and harms of tenecteplase at different doses.
Lumbar spinal ganglion cyst: A systematic review with case illustration
Shivam Rana a,1, Anjali Pradhan a,g, Joshua Casaos a, Khashayar Mozaffari a, Farinaz Ghodrati a,g, Brianna Sugimoto h, Isaac Yang a,b,c,d,e,f,g,*, Daniel T. Nagasawa
doi : 10.1016/j.jns.2022.120539
Volume 445, 15 February 2023, 120539
Ganglion cysts are benign soft tissue lesions found in joints, most commonly wrists. The incidence for juxtafacet cysts, the condition under which spinal ganglion cysts are categorized, is between 0.06% and 5.8%.
Cerebral amyloid-β deposition in patients with heart disease or carotid occlusive disease: A systematic review and meta-analysis
Naomi Louisa Paula Starmans a,*, Anna Elisabeth Leeuwis b, Geert Jan Biessels a, Laurens Jaap Kappelle a, Wiesje Maria van der Flier b,c, Nelleke Tolboom
doi : 10.1016/j.jns.2023.120551
Volume 445, 15 February 2023, 120551
Cardiovascular disease is an important contributor to cognitive impairment. This likely involves prototypical vascular disease mechanisms like ischemia, but cardiovascular disease might also impact the brain by accelerating cerebral amyloid-β accumulation. We aimed to determine whether there is an association between heart disease or carotid occlusive disease (COD) and cerebral amyloid-β burden.
MDS-UDPRS-III in the diagnosis of idiopathic Normal Pressure Hydrocephalus and identification of candidates for Ventriculo-Peritoneal Shunting surgery. Results from a retrospective large cohort of patients
Enrico Belgrado a,1, Yan Tereshko b,*,1, Francesco Tuniz c, Christian Lettieri a, Daniele Bagatto d, Sara Fabbro c, Daniele Piccolo c, Gian Luigi Gigli b, Miran Skrap c, Mariarosaria Valente
doi : 10.1016/j.jns.2022.120536
Volume 445, 15 February 2023, 120536
To evaluate the entity of extrapyramidal signs, characterize them and evaluate the dynamics of change by the mean of MDS-UPDRS-III in iNPH patients after the TT to determine if this tool may help the diagnosis of iNPH and the identification of candidates for Ventriculo-Peritoneal Shunting.
Visual suppression of vestibulo-ocular reflex in patients treated with carotid artery revascularization: A potential biomarker for cerebral perfusion
Shigeta Miyake a,1, Koji Takahashi b,1, Yasunobu Nakai a, Yu Amano c, Ryoo Yamamoto c, Kazumitsu Amari a, Hiroya Hara b, Ken Johkura
doi : 10.1016/j.jns.2022.120534
Volume 445, 15 February 2023, 120534
Carotid endarterectomy (CEA) and carotid artery stenting (CAS) are common treatments for ischemic stroke prevention in patients with carotid artery stenosis. However, the beneficial effects of CEA/CAS for cerebral hypoperfusion due to carotid artery stenosis have yet to be fully established.
Trends in concussion mechanism of injury during the COVID-19 pandemic
Olivia Schaffer a, Frank Xie a, Debby Cheng a, Scott N. Grossman a,c, Steven L. Galetta a,c, Laura J. Balcer
doi : 10.1016/j.jns.2022.120538
Volume 445, 15 February 2023, 120538
The primary objective was to determine the effect of the COVID-19 pandemic on volume, demographics, and mechanisms of injury (MOI) for patients seen at an urban multidisciplinary concussion center. During the first phase of the pandemic in the United States, stay-at-home orders led to decreased group activities and required cancellation of outpatient appointments or initiation of telemedicine visits.
Glutamic acid decarboxylase antibody-associated neurological syndromes: Clinical and antibody characteristics and therapy response
Marie Madlener a,*, Christine Strippel b, Franziska S. Thaler c, Kathrin Doppler d, Klaus P. Wandinger e, Jan Lewerenz f, Marius Ringelstein g,h, Rosa Roessling i, Til Menge h, Jonathan Wickel j, Christoph Kellingshaus k, Sigrid Mues l, Andrea Kraft m, Andreas Linsa n, Simone C. Tauber o, Florian Then Berg p, Stefan T. Gerner q, Asterios Paliantonis r, Alexander Finke s, Josef Priller t, Ingo Schirotzek u,v, Marie Süße w, Kurt W. Sühs x, Christian Urbanek y, Makbule Senel f, Claudia Sommer d, Tania Kuempfel c, Harald Pruess i, Gereon R. Fink a,z, Frank Leypoldt aa, Nico Melzer b,g, Michael P. Malter a, German Network for Research on Autoimmune Encephalitis (GENERATE)1
doi : 10.1016/j.jns.2022.120540
Volume 445, 15 February 2023, 120540
Antibodies against glutamic acid decarboxylase (GAD-abs) at high serum levels are associated with diverse autoimmune neurological syndromes (AINS), including cerebellar ataxia, epilepsy, limbic encephalitis and stiff-person syndrome. The impact of low serum GAD-ab levels in patients with suspected AINS remains controversial.
Novel ways to modulate the vestibular system: Magnetic vestibular stimulation, deep brain stimulation and transcranial magnetic stimulation / transcranial direct current stimulation
A.A. Tarnutzer a,b,*, B.K. Ward c, A.G. Shaikh
doi : 10.1016/j.jns.2023.120544
Volume 445, 15 February 2023, 120544
Advances in neurotechnologies are revolutionizing our understanding of complex neural circuits and enabling new treatments for disorders of the human brain. In the vestibular system, electromagnetic stimuli can now modulate vestibular reflexes and sensations of self-motion by artificially stimulating the labyrinth, cerebellum, cerebral cortex, and their connections.
Self-reported factors contributing to delay in ALS diagnosis among primary care providers in a large Ohio-based US healthcare network
John A. Morren a,*, Carol Rheaume b, Erik P. Pioro
doi : 10.1016/j.jns.2022.120532
Volume 445, 15 February 2023, 120532
This study's primary objective is to identify self-reported factors that contribute to diagnostic delay in ALS among Primary Care Providers (PCPs).
The combination of heart rate variability and ABCD2 score portends adverse outcomes after minor stroke or transient ischemic attack
Yu Tian a,b,c,d,e, Yuesong Pan a,b,c,d,e, Mengxing Wang a,b,c,d,e, Xia Meng a,b,c,d,e, Xingquan Zhao a,b,c,d,e, Liping Liu a,b,c,d,e, Yongjun Wang a,b,c,d,e, Yilong Wang
doi : 10.1016/j.jns.2022.120522
Volume 445, 15 February 2023, 120522
The residual recurrent risk of stroke, which cannot be entirely explained by the traditional ABCD2 score, still existed. Heart rate variability (HRV), a method for reflecting the function of automatic nervous system (ANS), was a novel predictor of secondary stroke events.
Neurological soft signs are associated with reduced medial-lateral postural control in adolescent athletes
Elena M. Bonke a,b,c, Amanda Clauwaert d, Stefan M. Hillmann e, Uta Tacke f, Caroline Seer d,g, Eukyung Yhang h, Yorghos Tripodis h,i, Stian B. Sandmo j,k, Tim L.T. Wiegand a,c, David Kaufmann a,l, Elisabeth Kaufmann a,m, Sutton B. Richmond d,n, Malo Gaubert a,o,p, Johanna Seitz-Holland c, Alexander Leemans q, Stephan P. Swinnen d, Roald Bahr j, Ofer Pasternak c,r, Florian Heinen e, Inga K. Koerte a,b,c,s, Michaela V. Bonfert e,*,1, Jolien Gooijers
doi : 10.1016/j.jns.2022.120516
Volume 445, 15 February 2023, 120516
Neurological soft signs (NSS) are minor deviations from the norm in motor performance that are commonly assessed using neurological examinations. NSS may be of clinical relevance for evaluating the developmental status of adolescents. Here we investigate whether quantitative force plate measures may add relevant information to observer-based neurological examinations.
Association between multimorbidity with cognitive dysfunction in a Peruvian population
J. Carrasco-Zavala a, J.A. DÃaz-RG a, A. Bernabe-Ortiz b,c, M. Lazo-Porras
doi : 10.1016/j.jns.2023.120543
Volume 445, 15 February 2023, 120543
Previous studies have shown that multimorbidity is a risk factor for cognitive dysfunction (CD).Type 2 diabetes mellitus (T2DM) and hypertension (HT) are very common risk factors.The association between multimorbidity due to both diseases and CD has been understudied in low and middle-income countries, in which the strength of the association might be stronger.
Safety outcomes of early initiation of antithrombotic agents within 24Â h after intravenous alteplase at 0.6Â mg/kg
Tetsuya Chiba a, Takeshi Yoshimoto b,*, Shinichi Wada c, Masayuki Shiozawa a, Sohei Yoshimura a, Shunsuke Kimura a, Manabu Inoue a,d, Kazunori Toyoda a, Masafumi Ihara b, Masatoshi Koga
doi : 10.1016/j.jns.2023.120546
Volume 445, 15 February 2023, 120546
We examined outcome of acute ischemic stroke (AIS) with administration of antithrombotics within 24Â h after intravenous low-dose alteplase.
Can vigilance predict the status of safe functional gait and risk of falls in patients with peripheral vestibular disorders? A cross-sectional study
Christos Nikitas a,*, Evangelia Kontogianni b, Sofia Papadopoulou a, Michalis Tsoukatos a, Dimitris Kikidis
doi : 10.1016/j.jns.2023.120547
Volume 445, 15 February 2023, 120547
Peripheral vestibular disorders except from reflexes dysfunction correspond also to cognitive decline. The objectives of this cross-sectional study were to a) identify correlations among variables of functional gait, cognitive function, and perceived dizziness and b) explore variables that could be used as prognostic factors of functional gait in people with peripheral vestibular deficits.
M1/precuneus ratio as a surrogate marker of upper motor neuron sign in ALS
Wataru Sako a,b,*, Shotaro Haji b, Takashi Abe c, Yusuke Osaki b, Yuki Matsumoto c, Masafumi Harada c, Yuishin Izumi
doi : 10.1016/j.jns.2023.120548
Volume 445, 15 February 2023, 120548
To investigate whether primary motor cortex (M1) volume measured with an automated approach in MRI reflects upper motor neuron dysfunction and whether it can serve as a potential diagnostic and/or disease-tracking biomarker for amyotrophic lateral sclerosis (ALS).
Limb positioning and magnitude of postural tremor ratings: A study of 100 essential tremor cases
Allison Powell, Diane S. Berry, Meagen Salinas, Elan D. Louis
doi : 10.1016/j.jns.2023.120550
Volume 445, 15 February 2023, 120550
Essential tremor (ET) is a highly prevalent movement disorder. As the diagnosis is purely clinical, it is important for clinicians to develop a reliable taxonomy of signs and symptoms of ET. Here, we investigate two common clinical maneuvers for determining the presence and severity of postural tremor in ET cases: the evaluation of tremor observed when arms are held in the outstretched and wing posture positions.
A real-world analysis of factors associated with high healthcare resource utilization and costs in patients with myasthenia gravis receiving second-line treatment
Angela Ting a,*, Tyler Story a, Coralie Lecomte b, Adina Estrin b, Sahar Syed b, Edward Lee
doi : 10.1016/j.jns.2022.120531
Volume 445, 15 February 2023, 120531
Despite current treatments, patients with myasthenia gravis (MG) experience unpredictable and inadequately controlled symptoms, lending to variability in the clinical and economic burden of disease.
Response to letter to Editor
Akira Tsujino*, Atsushi Nagaoka, Shunsuke Yoshimura
doi : 10.1016/j.jns.2023.120541
Volume 445, 15 February 2023, 120541
Comment on: Nagaoka, A. et al., Motor end-plate analysis to diagnose immune-mediated myasthenia gravis in seronegative patients. J Neurol Sci, 2022. 443: p. 120494
Sarah Hoffmanna,*, Werner Stenzelb, Andreas Meisel
doi : 10.1016/j.jns.2023.120542
Volume 445, 15 February 2023, 120542
Tissue hyperoxia is not a risk factor for cerebral vasospasm following subarachnoid hemorrhage
Michele Salvagno*, Fabio Silvio Taccone, Elisa Gouvea Bogossian
doi : 10.1016/j.jns.2022.120535
Volume 445, 15 February 2023, 120535
Impact of concomitant use of opicapone during levodopa–carbidopa intestinal gel treatment
Noriyuki Miyaue*, Yuko H. Ito, Chikako Ochi, Yuki Yamanishi, Satoshi Tada, Rina Ando, Masahiro Nagai
doi : 10.1016/j.jns.2023.120549
Volume 445, 15 February 2023, 120549
